Exosome-related technologies have been developing rapidly over the past few years and substantial growth is expected for the market as they get integrated into the fields of liquid biopsy, precision medicine and regenerative medicine. In particular, cancer derived exosomes influence the invasive potential of cells by regulating angiogenesis, metastasis, and immunity, making them an extremely useful source of biomarkers for use in cancer detection, diagnosis, and therapeutic selection. [Read more…]
List of Exosome Companies: Tiny Packages, Enormous Potential
Exosomes are small vesicles ranging from 30-100nm in size that are found in nearly all eukaryotic fluids and facilitate a range of important cellular functions. Although exosomes were discovered more than 30 years ago, it was not until recently that the scientific community began to give credit to exosomes for a range of promising traits. [Read more…]
Venture Capital Flows into the Exosome Industry Led by Industry Stalwarts
Venture capital activity within the exosome industry has gained substantial momentum in recent years, as more as more investors pursue this promising cell-free therapeutic technology. While funding events slowed in the past year and a half due to the Covid pandemic, funding events from 2016 to 2021 were particularly robust—with companies like Evox Therapeutics, ILIAS Biologics, Codiak BioSciences, ExCoBio, Evox Therapeutics, ArunA Bio, and Capricor Therapeutics leading the charge. [Read more…]
OmniSpirant Limited and EVerZom Announce the Launch of INSPIRE; an EU Project funded under the Horizon Europe research and innovation programme to develop a ground-breaking inhaled gene therapy for the treatment of lung cancer based on extracellular vesicles
Galway, 25th November 2022 –OmniSpirant Limited and EVerZom are delighted and honoured to announce the launch of INSPIRE, a €12.8 million lung cancer project funded by Horizon Europe. In one of the largest ever grants for preclinical research in lung cancer, OmniSpirant in collaboration with our European partners spanning across biotechnology, medical devices, cancer research, academia and patient advocacy, are already actively working on the project deliverables, and recently met in Galway, Ireland for the official kick-off meeting (see the picture below taken on the 28th October 2022). [Read more…]
What is the Current State of Stem Cell Derived Exosomes?
Prior to 2007, exosomes were largely considered to be tiny “trash sacs” thrown out of living cells. Around 2007, it as discovered that exosomes carry RNAs and miRNAs, along with other molecules to regulate the expression of genes between cells. This discovery paved the way for the scientists to search for improved techniques for the exploitation of exosomes in treating diseases. [Read more…]
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 23
- Next Page »